360. Breakthrough Invasive Pulmonary Aspergillosis During Isavuconazole Prophylaxis in Patients with Hematologic Malignancies: A Single-Center Experience

BACKGROUND: Isavuconazole (ISA) is an attractive candidate for prophylaxis against invasive mould infections (IMIs) due to its broad-spectrum activity, ease of dosing, favorable side-effect profile, and limited drug–drug interactions. Clinical experience using ISA prophylaxis in high-risk patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontana, Lauren, Lewis II, James S, Hakki, Morgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255608/
http://dx.doi.org/10.1093/ofid/ofy210.371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255608/
http://dx.doi.org/10.1093/ofid/ofy210.371

Ejemplares similares